Publication:
Association of Central Retinal Vein Obstructions and Anticardiolipin Antibodies

dc.authorscopusid56378253000
dc.authorscopusid6701577980
dc.authorscopusid6603655021
dc.authorscopusid6603702621
dc.contributor.authorBirinci, H.
dc.contributor.authorBirinci, A.
dc.contributor.authorEkinci, B.
dc.contributor.authorÖge, I.
dc.date.accessioned2020-06-21T09:14:41Z
dc.date.available2020-06-21T09:14:41Z
dc.date.issued2003
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Birinci] Hakki, Department of Ophthalmology, Ondokuz Mayis School of Medicine, Samsun, Samsun, Turkey, Tip Fakultesi, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Birinci] Asuman, Department of Clinical Microbiology, Ondokuz Mayis School of Medicine, Samsun, Samsun, Turkey; [Ekinci] Bora, Department of Clinical Microbiology, Ondokuz Mayis School of Medicine, Samsun, Samsun, Turkey; [Öge] Ihsan, Department of Ophthalmology, Ondokuz Mayis School of Medicine, Samsun, Samsun, Turkeyen_US
dc.description.abstractIn recent years, a relationship between the rising levels of anticardiolipin antibodies (ACA) and recurrent venous and arterial thrombotic complications has been shown. In this study, we aimed to determine whether there was a relation between central retinal venous obstruction (CRVO) and ACA. Blood samples from 24 patients with CRVO and 29 age matched controls were studied for IgG and IgM ACA by Enzyme-Linked Immunoabsorbant assay (ELISA). Antibody levels for IgG ACA and for IgM ACA greater than 20 GPL U/ml and 10 MPL U/ml were accepted as positive. IgG ACA positivity was found in 37.5% of CRVO patients and 20.6% in controls. On the other hand, IgM ACA positivity was detected in 29.1% and 17.2% of CRVO patients and controls groups, respectively. No statistically significant differences were found between patients and control groups for IgG ACA and IgM ACA positivity (p>0.05). Although, we found no statistically significant differences with regard to the levels of ACA in CRVO patients compared to controls, we believe that the finding of markedly higher levels of ACA in CRVO patients may help to identify the cause of CRVO in cases of unknown aetiology.en_US
dc.identifier.endpage4en_US
dc.identifier.issn1300-2996
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-0042821606
dc.identifier.startpage1en_US
dc.identifier.volume20en_US
dc.language.isoenen_US
dc.relation.ispartofOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.journalOndokuz Mayis Universitesi Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnticardiolipin Antibodyen_US
dc.subjectCentral Retinal Vein Obstructionen_US
dc.titleAssociation of Central Retinal Vein Obstructions and Anticardiolipin Antibodiesen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files